NCT06316466View on ClinicalTrials.gov

Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis

RecruitingOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

March 30, 2024

Conditions
Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
Interventions
OTHER

Lp(a)

The cut-off value for Lp (a) was determined based on one-year survival rates after diagnosis. Patients were then categorized into the high and low Lp (a) groups.

Trial Locations (1)

Unknown

RECRUITING

Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors
lead

jingxue

OTHER